US Congress House Bill 8139 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on September 1 2020 - 25% progression, died in committee
Action: 2020-09-01 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.

SUPPLIES Act of 2020 Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020

Rep. Gus Bilirakis [R-FL]

Rep. Darren Soto [D-FL]

Date	Chamber	Action
2020-09-01	House	Referred to the House Committee on Energy and Commerce.
2020-09-01	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/8139/all-info
Text	https://www.congress.gov/116/bills/hr8139/BILLS-116hr8139ih.pdf